Building a database from real pancreatic cancer cases
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study collects real hospital records from people treated for pancreatic cancer to build a large database. It aims to use these real cases to improve future care, so your information could help doctors learn and treat others better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been treated for pancreatic cancer as a hospital inpatient.
- Your hospital records must be complete, including test results, progress notes, and treatment plans.
- Cases where a team of specialists discussed your treatment are especially wanted.
- You should have received a full course of care, not just a quick emergency or clinic visit.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects medical and lab information from adults with pancreatic cancer to help researchers understand care and outcomes. You may be asked for follow-up visits and basic data, and it may be used to improve future treatments.
This study collects information from people diagnosed with pancreatic cancer. It aims to improve care by learning from your medical records.
This study uses data from patients with pancreatic conditions and healthy people to improve care through computer analysis. It may help researchers develop better tools for diagnosis and treatment.
This study builds a computer model to predict how well pancreatic cancer patients will respond to surgery and what their long-term outcomes might be. Researchers use CT scans, blood tests, and medical records from patients who had pancreatic cancer surgery to teach the model to recognize patterns that help predict outcomes.
This trial studies metastatic pancreatic cancer by taking a small tissue sample and analyzing its genes. It may help doctors better understand which cancer subtypes patients have, which can guide future treatment choices.
This study collects health information and stored samples (biospecimens) to learn more about pancreatic diseases, including cancer and early warning changes. It may help researchers understand who is at higher risk and improve future testing and care.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.